Market Overview:
The global immunoglobulin E (IgE) allergy blood tests market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of allergic diseases, rising awareness about IgE-mediated allergies, and technological advancements in immunoassay platforms. The global immunoglobulin E (IgE) allergy blood tests market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into assays and kits, elisa testing kits, fluorescent enzyme immunoassays (FEIA) testing kits, chemiluminescent immunoassays (CLIA), reagents & consumables; and analyzers. On the basis of application; hospitals are expected to account for a major share in terms of revenue in 2018 owing to an increase in number of patients with IgE-mediated allergies seeking diagnosis and treatment options from these institutions.
 Allergy Blood Tests Industry Outlook.svg)
Product Definition:
An immunoglobulin E (IgE) allergy blood test is a laboratory test used to measure the amount of IgE antibody in your blood. IgE antibodies are produced in response to allergens, which are substances that can cause an allergic reaction. The presence of elevated levels of IgE antibodies may indicate an allergy.
Assays and Kits:
Allergy blood tests are used for the detection of immunoglobulin E (IgE) antibodies in the blood. These tests also determine if there is an active form of immunoglobulin E allergy present in the body. The test works by detecting specific IgE antibodies that bind to a allergen and create an immune response, this leads to various symptoms such as itching, swelling & redness of eyes or skin, shortness of breath & wheezing among others.
Elisa Testing Kits:
Elisa Testing Kits and it's usage in Immunoglobulin E (IgE) Allergy Blood Tests market is driven by factors such as rising prevalence of allergic disorders, increasing geriatric population base, and growing awareness about the disease among consumers. According to the estimates published by the World Health Organization (WHO), around 3 million people die every year due to asthma.
Application Insights:
The market is segmented based on application as hospitals, diagnostic centers, specialty clinics and emergency ambulatory centers. Hospitals dominated the overall market in terms of revenue share in 2017 owing to factors such as increasing prevalence of allergic diseases and rising number of hospital admissions for these diseases.
Furthermore, due to the presence of a well-established healthcare infrastructure with highly skilled personnel and advanced equipment in most countries across the Asia Pacific region; this segment has been dominating this global immunoglobulin E (IgE) allergy blood tests industry since inception. The diagnostics center segment is expected to witness lucrative growth over the forecast period owing to factors such as an increase in incidence rates for allergic rhinitis among children coupled with high demand for point-of-care testing products.
Regional Analysis:
North America dominated the global immunoglobulin E (IgE) allergy blood tests market in 2017. This can be attributed to rising awareness about early diagnosis, presence of well-established healthcare facilities, and availability of advanced treatment options in this region. In addition, increasing prevalence of allergic disorders is also expected to drive the demand for these tests over the forecast period. For instance, as per a recent study published by National Institute of Health (NIH), around 6 million people in U.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available diagnostic procedures coupled with rising incidences of atopic dermatitis & other skin allergies among children & adults resulting from environmental triggers such as pollution and bites from houseflies & mosquitoes etc).
Growth Factors:
- Increasing incidence of allergic diseases: The increasing incidence of allergic diseases is one of the key growth drivers for the Immunoglobulin E (IgE) Allergy Blood Tests market. According to a study by the World Health Organization, the prevalence of asthma has increased by 100% in the last two decades. This is attributed to changes in lifestyle and environmental factors. The rising awareness about allergies and their diagnosis and treatment is also propelling demand for Immunoglobulin E (IgE) Allergy Blood Tests products.
- Technological advancements: Technological advancements are leading to innovative products that are helping in early diagnosis and treatment of allergies. This is aiding growth prospects for the Immunoglobulin E (IgE) Allergy Blood Tests market. For instance, recent technological advances have led to development of point-of-care tests that can provide results within minutes, which helps physicians make timely decisions about patient care.
- GlaxoSmithKline plc announced a partnership with Cambridge University’
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoglobulin E (IgE) Allergy Blood Tests Market Research Report
By Type
Assays and Kits, Elisa Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA), Reagents, Consumables, Analyzers
By Application
Hospitals, Diagnostic Centers, Specialty Clinics, Emergency Ambulatory Centers
By Companies
Abionic SA, Amerimmune LLC, AXO Science SAS, Biovator AB (Inactive), Children's Hospital Boston, China Medical Technologies Inc (Inactive), Cytognos, SL, EUROIMMUN US LLC, Ferrer inCode SL, HOB Biotech Group Suzhou Co Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Immunoglobulin E (IgE) Allergy Blood Tests Market Report Segments:
The global Immunoglobulin E (IgE) Allergy Blood Tests market is segmented on the basis of:
Types
Assays and Kits, Elisa Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA), Reagents, Consumables, Analyzers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Specialty Clinics, Emergency Ambulatory Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abionic SA
- Amerimmune LLC
- AXO Science SAS
- Biovator AB (Inactive)
- Children's Hospital Boston
- China Medical Technologies Inc (Inactive)
- Cytognos, SL
- EUROIMMUN US LLC
- Ferrer inCode SL
- HOB Biotech Group Suzhou Co Ltd
 Allergy Blood Tests Market Overview.svg)
Highlights of The Immunoglobulin E (IgE) Allergy Blood Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Assays and Kits
- Elisa Testing Kits
- Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
- Chemiluminescent Immunoassays (CLIA)
- Reagents
- Consumables
- Analyzers
- By Application:
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Emergency Ambulatory Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoglobulin E (IgE) Allergy Blood Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Allergy Blood Tests Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IgE allergy blood tests are used to measure the level of IgE in a person's blood. IgE is a type of antibody, and people with allergies have high levels of this antibody. IgE allergy blood tests can help diagnose allergic reactions and determine whether treatment is necessary.
Some of the major players in the immunoglobulin e (ige) allergy blood tests market are Abionic SA, Amerimmune LLC, AXO Science SAS, Biovator AB (Inactive), Children's Hospital Boston, China Medical Technologies Inc (Inactive), Cytognos, SL, EUROIMMUN US LLC, Ferrer inCode SL, HOB Biotech Group Suzhou Co Ltd.
The immunoglobulin e (ige) allergy blood tests market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunoglobulin E (IgE) Allergy Blood Tests Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunoglobulin E (IgE) Allergy Blood Tests Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunoglobulin E (IgE) Allergy Blood Tests Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunoglobulin E (IgE) Allergy Blood Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunoglobulin E (IgE) Allergy Blood Tests Market Size & Forecast, 2018-2028
4.5.1 Immunoglobulin E (IgE) Allergy Blood Tests Market Size and Y-o-Y Growth
4.5.2 Immunoglobulin E (IgE) Allergy Blood Tests Market Absolute $ Opportunity
Chapter 5 Global Immunoglobulin E (IgE) Allergy Blood Tests Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
5.2.1 Assays and Kits
5.2.2 Elisa Testing Kits
5.2.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
5.2.4 Chemiluminescent Immunoassays (CLIA)
5.2.5 Reagents
5.2.6 Consumables
5.2.7 Analyzers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunoglobulin E (IgE) Allergy Blood Tests Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Specialty Clinics
6.2.4 Emergency Ambulatory Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunoglobulin E (IgE) Allergy Blood Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunoglobulin E (IgE) Allergy Blood Tests Analysis and Forecast
9.1 Introduction
9.2 North America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
9.6.1 Assays and Kits
9.6.2 Elisa Testing Kits
9.6.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
9.6.4 Chemiluminescent Immunoassays (CLIA)
9.6.5 Reagents
9.6.6 Consumables
9.6.7 Analyzers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Specialty Clinics
9.10.4 Emergency Ambulatory Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunoglobulin E (IgE) Allergy Blood Tests Analysis and Forecast
10.1 Introduction
10.2 Europe Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
10.6.1 Assays and Kits
10.6.2 Elisa Testing Kits
10.6.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
10.6.4 Chemiluminescent Immunoassays (CLIA)
10.6.5 Reagents
10.6.6 Consumables
10.6.7 Analyzers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Specialty Clinics
10.10.4 Emergency Ambulatory Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunoglobulin E (IgE) Allergy Blood Tests Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
11.6.1 Assays and Kits
11.6.2 Elisa Testing Kits
11.6.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
11.6.4 Chemiluminescent Immunoassays (CLIA)
11.6.5 Reagents
11.6.6 Consumables
11.6.7 Analyzers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Specialty Clinics
11.10.4 Emergency Ambulatory Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunoglobulin E (IgE) Allergy Blood Tests Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
12.6.1 Assays and Kits
12.6.2 Elisa Testing Kits
12.6.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
12.6.4 Chemiluminescent Immunoassays (CLIA)
12.6.5 Reagents
12.6.6 Consumables
12.6.7 Analyzers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Specialty Clinics
12.10.4 Emergency Ambulatory Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunoglobulin E (IgE) Allergy Blood Tests Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Type
13.6.1 Assays and Kits
13.6.2 Elisa Testing Kits
13.6.3 Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
13.6.4 Chemiluminescent Immunoassays (CLIA)
13.6.5 Reagents
13.6.6 Consumables
13.6.7 Analyzers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunoglobulin E (IgE) Allergy Blood Tests Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Specialty Clinics
13.10.4 Emergency Ambulatory Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunoglobulin E (IgE) Allergy Blood Tests Market: Competitive Dashboard
14.2 Global Immunoglobulin E (IgE) Allergy Blood Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abionic SA
14.3.2 Amerimmune LLC
14.3.3 AXO Science SAS
14.3.4 Biovator AB (Inactive)
14.3.5 Children's Hospital Boston
14.3.6 China Medical Technologies Inc (Inactive)
14.3.7 Cytognos, SL
14.3.8 EUROIMMUN US LLC
14.3.9 Ferrer inCode SL
14.3.10 HOB Biotech Group Suzhou Co Ltd
